HIV/AIDS Testing

Published by: Global Industry Analysts

Published: Oct. 1, 2008 - 413 Pages

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations

DisclaimersI-

Data Interpretation & Reporting Level

Product Definitions and Scope of StudyI-

DefinitionsI-

HIV/AIDS Screening TestsI-

HIV/AIDS Confirmatory TestsI-

HIV/AIDS Monitoring Tests

II. EXECUTIVE SUMMARY

1. Industry OverviewI

Worldwide HIV/AIDS Testing Market - An Analysis

Regional Analysis

The US

Asia Pacific

EuropeI

Majority of HIV Infections Seen in Developing Countries

Segment Analysis

HIV/AIDS Screening

Confirmatory Test MarketI

HIV/AIDS Monitoring Market

Growth Drivers

Rapid Testing- Displays High PotentialI

Molecular Diagnostics Register Strong Growth in Blood Screening Markets

Ultra-Rapid HIV-screening Tests- A Strong Fight against HIV-Epidemic

Emergency Room Testing to Help HIV Diagnosis

OTC HIV Tests to See The Light?I

Leading Players

FDA Approved Rapid HIV Tests

HIV/AIDs Diagnostics Market Participants - Product MatrixI

2. Aids: A Global EpidemicI

Facts & FiguresI

Table 1: HIV/AIDS Statistics Worldwide: End-2007I

Table 2: Worldwide Living Population Infected withHIV/ AIDS (2007-End) (includes corresponding Graph/Chart)

Table 3: Worldwide HIV & AIDS Incidences (End-2007): A Regional Breakdown for Living and Newly Infected Cases (includes corresponding Graph/Chart)I

Table 4: HIV/AIDS Cases (Living & New Infections) in Adults and Children Worldwide: Breakdown by Region- End 2007 (includes corresponding Graph/Chart)

Table 5: Worldwide Deaths Due to AIDS (2007-End) (includes corresponding Graph/Chart)I

Table 6: HIV/AIDS Cases in Adults and Children Worldwide: Breakdown by Region-End 2007I

Table 7: Countries With the Highest Number of People Living with HIV: 2003 (includes corresponding Graph/Chart)

AIDS : A Serious Threat

Catching them Young

Estimated Number of New HIV Infections in Young PeopleI

Ant

3. Understanding the DiseaseI

Mechanism of ActionI

SymptomsI

Full-Blown AIDS

Transmission of HIVI

On the Brighter Side

HIV Therapy

The Search ContinuesI

Infection Process - Targets for HIV TherapyI

4. Diagnosis of HIV/AidsI

Testing: The Basis for AIDS Prevention and Treatment

Blood Processing

The Earliest Time to Detect InfectionI

Testing Plagued by Problems Such As

Major Drawbacks of Laboratory Diagnosis of HIV Infections

Rapid Tests - Suitable for Developing CountriesI

5. HIV TestsI

Testing Subject to Strict Rules

Diagnostic Tests

I. Antibody Tests

A. HIV-1 Screening TestsI

Test Methodology

a. Enzyme-linked Immunosorbent Assays/Enzyme Immunoassays (ELISA/EIA)I

b. Home AccessHIV-1 test system/Dried Blood Spot

c. Rapid TestsI

Generic Assay Formats in Rapid Test

The Dot Blot Rapid Test

Agglutination TestsI

Solid Phase Test

Immunochromatographic strip (ICS) Tests

Rapid Serological Tests Vs. ELISA Tests

B. HIV-1 Antibody Confirmatory Tests

a. The Western Blot TestI

Commonly Used in Developed Countries

Interpretation of ResultsI

Modified Western Blots

b. Indirect Immunofluorescent Antibody Assay (IFA)

c. Line Immunoassay

d. Radioimmunoprecipitation Assay (RIPA)

C. HIV-2 Diagnostic Tests and HIV Group “OI

Testing Protocols

Types of Antibody Tests Based on Sample

i. Traditional Blood Antibody TestsI

ii. Dried Blood Spot (DBS) Sampling Technique

Blood Tests Are Highly Expensive

iii. Other Alternatives in Samples

Oral Testing for HIV

Urine TestsI

II. Viral Identification Assays

A. p24 Antigen Test

B. Qualitative PCR Tests

C. Viral CultureI

Monitoring Tests

A. Lymphocyte AnalysisI

B. Viral Load Tests

Levels of CD4 and Viral Load in AIDS

C. Drug Resistance TestsI

Main Types

i. Genotyping Tests

ii. Phenotyping Tests

Molecular Diagnostics and Gene Detection Products

DNA Probe-Based ProductsI

Direct Assays

Amplification

Amplification MethodologiesI

6. Technology ReviewI

PCR: A Promising Development in HIV/AIDS Monitoring Market

DNA Probes are Highly Specific and Sensitive

OCA-particles Based Detection System-Offers Increased Accuracy

Home HIV Tests: Unfolding a New Era of Testing

Yet NascentI

Not Without Share of Objections

Home Access: Monopolizing the Home HIV Test Kit Market

Drawbacks of Blood-Based TestsI

7. RegulationsI

Overview

UN’s Testing Policies in Peacekeeping Force

Anonymous Versus Confidential Diagnostic Testing for HIV infection in US

Regulatory Approval for Rapid HIV Test Kits in USI

HIV Testing - Mandatory in US Blood BanksI

8. New Product Approvals & LaunchesI

Calypte Launches Aware Messenger™

Abbott Launches Advanced Viral Load Test

MedMira Launches MiraCare™ Rapid Tests with Extended Shelf Life

University Researcher Develops Novel HIV/AIDs Antibody Test Kit

bioMérieux Introduces VIKIA® HIV 1 / 2 Rapid HIV TestI

Dr Lal Pathlabs Develops Inexpensive HIV Monitoring Test

MedMira to Launch Multiplo™ Rapid HIV/HCV Antibody Test

Shanghai Kehua Develops New HIV/AIDS Test Kit for Faster Diagnosis

INSTI™ HIV Test Kit from bioLytical™ Receives European CE Mark

Rockeby Biomed Gains Approval from MOH to Sell OraQuick across SingaporeI

FDA Approves Chembio’s Rapid HIV Tests for Sale in the US

MiraWell Whole Blood Rapid HIV Test Receives Approval from China SFDA

MiraCare Rapid HIV Antibody Test Receives CE Mark

Calypte Receives Approval for Marketing Aware Rapid HIV Tests in KenyaI

FDA Approves Bayer’s Automated HIV Antibody Test Product

SA Government Approves Marketing of Calypte’s Aware OMT HIV Test Product

Calypte Introduces OTC Version of Aware HIV Test in UAE

Roche Obtains European Union’s CE Mark for its cobas TaqScreen MPX TestI

MedMira Registers Rapid HIV/ADIS Test Products for Latin American Market

bioLytical Gains Health Canada’s Approval for Marketing INSTI HIV Test Kit

Calypte’s Aware BSP HIV 1/2 Test Product Receives Malaysian Government’s

Clearance

FDA Approves Upgrades to Reveal G2 Rapid HIV Test

MedMira Introduces OTC Version of MiraCare in Select Asian MarketsI

Calypte Includes Dried Blood Specimen-Based Testing Capability into HIV-1 BED Incidence

EIA Test

Calypte’s Aware™ HIV-1/2 BSP Approved for Marketing in Zimbabwe

FDA Approves Rockville Facility for Manufacturing HIV-1 Urine EIA Screening

Test

OraSure Introduces OraQuick ADVANCE Rapid HIV Test in MexicoI

Adaltis Develops Advanced Detect-HIV™ Test for Early Detection of HIV

Infection

Xenomics Develops HIV DNA Detection Technology

Abbott and Celera Diagnostics Receive CE Certification

Bio-Rad Receives FDA Approval for HIV-1& HIV 2 Rapid TestI

FDA Approval for MedMira’s Enhanced Rapid HIV Test

Roche Receives CE Mark Certification for Virology Tests

Roche Receives FDA Approval for COBAS AmpliScreen Test

Chembio Diagnostics Launches HIV Stat-Pak Dipstick

Medical Services Develops Next Generation HIV Test KitsI

Bio-Rad’s Multispot HIV-1/HIV-2 rapid test Approved by FDA

Abbott Receives CE Mark Certification for PCR TestI

Bayer Receives CE Mark Certification for TRUGENE® HIV-1

MedMira Receives Health Canada Approval for Rapid HIV Test

OraSure Receives FDA Approval for Oral Fluids and Plasma

Roche Receives FDA Approval for Diagnostic Test

Trinity Receives FDA Waiver for Un

bioMérieux Unveils VIDAS® HIV Duo Ultra and Duo Quick HIV TestsI

OraQuick® Rapid HIV-1/2 Antibody Assay Approved by the FDA

MedMira Launches Reveal™ G2

OraSure Launches OraQuick® ADVANCE Rapid HIV Test

Celera Diagnostics Obtains FDA Clearance for Enhanced ViroSeq™I

Calypte Unveils HIV-1/2 Oral Fluid Rapid Tests

Bio-Rad’s HIV-1/HIV-2 PLUS O EIA Assay Approved by the FDA

OraQuick HIV-1 Test Approved by FDA for Use with Venuous Whole Blood

Bio-Rad Receives FDA Approval for HIV-1/HIV- 2 PLUS O Test

Calypte Introduces Urine Based HIV-1 Assay in AfricaI

China Develops Novel HIV Testing Reagent

Calypte Receives FDA Approval for Western Blot Supplemetary TestI

9. Recent Industry ActivityI

MedMira Bags Supply Contract from PAHO

MedMira Seeks Patent for Latest Rapid Test Platform

US FDA Approves HIV Home Test Kit

Abbott Attains Supplemental FDA Approval for RealTime HIV- 1 Viral Load Test

USCDC Awards Federal Grant to District of Columbia for HIV TestingI

Premier Includes Roche COBAS HIV-1 Monitoring Test in Contract

MedMira Receives USAID Approval for Reveal G3 Rapid HIV Test

Calypte Biomedical Inks Agreement with Fusion Capital

Roche Inks Agreement with Clinton FoundationI

Ortho-Clinical Attains FDA Approval for HIV Test

Geneart Awarded Patent for HIV Vaccine

Crucell’s Adenovirus Vector Enters Phase I Clinical Studies

MedMira to Expand Operations in Eastern EuropeI

Calypte Initiates Sale of Aware™ HIV-1/2 OMT Oral Fluid Test in India

Calypte Receives Approval for Aware HIV-1/2 OMT Test

Bundi Opts for SurgiLance Safety Lancet

Chembio Diagnostics Receives Sublicense for HIV-2 PatentI

Calypte Receives USAID Approval

Roche’s Latest HIV-1 Test Receives FDA Approval

Beckman Coulter Receives GrantI

Oregon Medical Adopts Roche Diagnostics' HIV Test

OraSure Inks Agreement with Supply Chain Management System

Bio-Rad Enters into Mult

CytoDyn Pockets Advanced Genetic Technologies

Aethlon Partners with ImQuestI

Quest Diagnostics Receives License from Pathway

OraSure Inks Agreement with Constella Group

LabCorp to Offer Fully Automated Real-Time HIV Test of Roche Diagnostics

Abbott Receives FDA Approval for RealTime HIV-1 Test

Abbott Receives Health Canada ApprovalI

Novartis Receives Health Canada Approval

Medical Services Completes Trials of VScan Hepatitis C and HIV Test Kit

Health Canada Approves Versant 440 Molecular Systems

OraSure Receives CE Mark for OraQuick ADVANCE HIV Test

MedMira Receives Approval for Multiplo HBV/HIV/HCVI

Roche Diagnostics Partners with ARK Diagnostics

Roche’ HIV Viral Load Test Used In Clinical Trials

Innogenetics and Bio-Rad Ink Licensing Agreement

OraSure Bags Contract From Madagascar Government

Calypte Receives Approval for Aware(TM) HIV-1/2 OMT Rapid Test

Siemens Acquires Bayer DiagnosticsI

Gen-Probe’s HIV Test Receives FDA Approval

Bayer Receives FDA Approval for Automated HIV Test

Inverness Receives Marketing Rights for Rapid HIV Test

Clinton Foundation Inks Agreement with Guava Technologies

MedMira Inks Distribution Agreement with Voden

Roche Bags CE Mark certificationI

Chembio Diagnostics Bags Major Contract

Calypte Receives Approval for HIV Test

Medical Services Expands Distribution Channel in South Africa

Rockeby Receives Approval from Singaporean Ministry of Health

MedMira Receives SFDA Approval

Roche Adopts Primagen’s DFS Technology

Calypte and Mineseeker to Supply Aware™ AIDS Test Kit Across AfricaI

OraSure Bags US$6 Million Order to Deliver HIV Test Kits

Trinity Biotech Enters into Agreement to Deliver Un

PPFA

Trinity Biotech Delivers Un

MedMira Bags Order from Exportrade for MiraWell Rapid HIV Tests

OraSure Receives Bulk Order for Rapid HIV Tests from CDC

MedMira Bags Order from Spree Trading for MiraWell Rapid HIV Tests

IRIS Acquires Leucadia with Plans to Introduce HIV & Cancer Testing ProductsI

Clindia to Distribute MiraCare Rapid HIV Test in the Netherlands

MedMira Bags Order from Goodman Medical

bioMérieux Bags Contract to Provide Equipment for HIV Viral Load Measurement

Bayer to Divest Diagnostic Division of Bayer Healthcare to Siemens

Novartis Acquires Chiron to Create a New Diagnostics & Vaccines Division

Abbott Enters into Agreement with Novation for Supplying OraQuick® ADVANCE™ HIV

TestsI

Roche Diagnostics Enters into Three-Year Agreement with Premier to Deliver Molecular

Products

MedMira Bags Order to Deliver MiraCare™ HIV Tests Across Europe

BD Partners with KEMRI to Provide Modern HIV/AIDS Testing Skills

KEMRI Sets Up Facility to Mass Produce AIDS Test Kit for African MarketI

MSI Bags Iranian Order for its Rapid VScan HIV/AIDS Test Kits

MSI Inks Contract to Deliver VScan HIV Test Kits Across China

MSI Inks Deals for Delivery of VScan HIV 1 & 2 Test Kits to Eastern Europe and

Taiwan

Abbott and OraSure Enter into Agreement

ViroLogic Offers License to GlaxoSmithKlineI

Bio-Rad Sublicenses HIV-2 Rapid Test Patent to OraSure

Biotech Cogstate Strikes a Deal with CDC

Calypte Receives CDC License for HIV Incidence Test

Calypte Biomedical Licences Rapid Test HIV-2 Patent from Bio-Rad

OraSure Receives Purchase Order from SAMHSAI

Roche Signs Agreement with Pasteur Institute and Bio-Rad

Roche Enters into Agreement with Korean Red Cross

Roche, Dade Behring and Chiron Enters into Licensing Agreement

Hedley and BioLytical Sign PactI

10. Focus on Select Global PlayersI

Abbott Laboratories Inc. (USA)

Abbott Molecular Inc. (USA)

Adaltis Inc. (Canada)

Siemens Healthcare Diagnostics Inc. (USA)I

Biomérieux SA (France)

Bio-Rad Laboratories Inc. (USA)

Calypte Biomedical Corporation (USA)I

Celera Group (LLC)

Gen-Probe Inc. (USA)

Innogenetics NV (Belgium)I

MedMira Laboratories, Inc. (Canada)

Medical Services International Inc. (Canada)

OraSure Technologies Inc. (USA)

Ortho-Clinical Diagnostics Inc. (USA)I

Roche Diagnostics (Switzerland)I

11. Global Market PerspectiveI

Unit AnalyticsI

Table 8: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 9: World Long-term Projections for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 10: World 10-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)I

Table 11: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 12: World Long-term Projections for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 13: World 10-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 201 (includes corresponding Graph/Chart)I

Table 14: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 15: World Long-term Projections for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 16: World 10-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Unit Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)I

Dollar AnalysisI

Table 17: World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 18: World Long-term Projections for HIV/AIDS Testing by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 19: World 10-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2000, 2005 & 2010 (includes corresponding Graph/Chart)I

Table 20: World Recent Past, Current & Future Analysis for HIV/AIDS Screening Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 21: World Long-term Projections for HIV/AIDS Screening Tests by Geographic Region - US, Canada,Japan, Europe, Asia-Pacific (excluding Japan), Latin America & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 22: World 10-Year Perspective for HIV/AIDS Screening Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)I

Table 23: World Recent Past, Current & Future Analysis for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 24: World Long-term Projections for HIV/AIDS Confirmatory Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 25: World 10-Year Perspective for HIV/AIDS Confirmatory Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)I

Table 26: World Recent Past, Current & Future Analysis for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 27: World Long-term Projections for HIV/AIDS Monitoring Tests by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 28: World 10-Year Perspective for HIV/AIDS Monitoring Tests by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)I

III. MARKET

1. The United StatesII

A. Market AnalysisI

Market OverviewI

Dollar AnalysisI

Unit AnalysisI

Competitive StructureII

Table 29: Leading Players in HIV Viral Load Testing Market in the US (2004- 2005E): Percentage Share Breakdown of Value Sales for Roche, Bayer, and Others (includes corresponding Graph/Chart)I

Table 30: Leading Players in HIV Viral Load Testing Market in the US (2004- 2005E): Percentage Share Breakdown of Value Sales Roche, Bayer, and Others (includes corresponding Graph/Chart)II

Rapid HIV Tests Display Rapid GrowthI

Leading PlayersI

FDA Approved Rapid Test KitsI

NAT Tests Score High in Blood BanksII

HIV/AIDS StatsII

Table 31: Percentage of HIV/AIDS Cases in the US, by Gender: 1993-2029 (includes corresponding Graph/Chart)II

Table 32: AIDS Diagnoses in the US (2005): Breakdown by Ethnic Groups/Race (includes corresponding Graph/Chart)I

Table 33: HIV Infected Persons in US (2005): Percentage Breakup by Ethnic Groups (includes corresponding Graph/Chart)II

Table 34: AIDS Cases by Exposure Category in the US: 2005 (includes corresponding Graph/Chart)I

Major End-Users of HIV/AIDS TestsI

HIV Testing Made Mandatory in Blood BanksII

Physician and Public Health Clinical MarketI

Home HIV TestsI

Efforts by OrganizationsII

Vermont Department of Health Suggests HIV Screening for Pregnant WomenI

FDA Approved HIV/AIDS Tests in the US market (1998-2004)II

Product LaunchesII

Strategic Corporate DevelopmentsII

Key PlayersI

Abbott Laboratories IncI

Abbott Molecular IncI

Bio-Rad Laboratories IncII

Calypte Biomedical CorporationI

Celera GroupI

Gen-Probe IncII

OraSure Technologies IncI

Ortho-Clinical Diagnostics IncI

Siemens Healthcare Diagnostics Inc. (USA)II

B. Market AnalyticsII

Table 35: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 36: US Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 37: US 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 38: US Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 39: US Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 40: US 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

2. CanadaII

A. Market AnalysisI

Market OverviewI

AIDS/HIV: Some Facts & FiguresII

Table 41: AIDS Cases in Canada by Ethnic Status: 2002 - 2006 (includes corresponding Graph/Chart)I

Table 42: AIDS Statistics for Canada by Exposure Category Till June 2007II

HIV StatisticsII

Table 43: AIDS/ HIV Diagnosis Trend in Canada: 1996-2006 (includes corresponding Graph/Chart)II

Table 44: AIDS and Positive HIV Cases in Canada by Age Group: 2006-End (includes corresponding Graph/Chart)I

HIV Incidence Among WomenII

Historical Stats- Late 1990sI

Product Launches/ApprovalsII

Strategic DevelopmentsII

Key PlayersI

Adaltis IncI

MedMira Laboratories, IncII

Medical Services International IncI

B. Market AnalyticsII

Table 45: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 46: Canadian Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 47: Canadian 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 48: Canadian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 49: Canadian Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 50: Canadian 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

3. JapanII

A. Market AnalysisI

Market OverviewI

HIV in JapanI

B. Market AnalyticsII

Table 51: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 52: Japanese Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 53: Japanese 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 54: Japanese Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 55: Japanese Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 56: Japanese 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4. EuropeII

A. Market AnalysisI

Market OverviewI

Regional AnalysisI

Segment AnalysisI

AIDs/HIV Stats - A ReviewII

Western EuropeII

Table 57: HIV Diagnosis in Western Europe: Facts and Figures by Country(2006) (includes corresponding Graph/Chart)II

Central EuropeII

Table 58: HIV Diagnosis in Central Europe: Facts and Figures by Country(2006) (includes corresponding Graph/Chart)II

Eastern EuropeII

Table 59: HIV Diagnosis in Eastern Europe: Facts and Figures by Country (2006) (includes corresponding Graph/Chart)II

RegulationsI

Antenatal HIV Testing in EuropeI

FinlandI

GermanyI

LuxembourgI

SwedenI

Product Approvals/LaunchesII

Strategic DevelopmentsII

B. Market AnalyticsI

Unit AnalyticsII

Table 60: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 61: European Long-term Projections for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 62: European 10-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Unit Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

Table 63: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 64: European Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 65: European 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Dollar AnalyticsII

Table 66: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 67: European Long-term Projections for HIV/AIDS Testing by Geographic Region - France, Germany, Italy, UK, Spain, & Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 68: European 10-Year Perspective for HIV/AIDS Testing by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, & Rest of Europe Markets for Years 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

Table 69: European Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/ AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 70: European Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 71: European 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4a. FranceII

A. Market AnalysisI

Market OverviewI

Key PlayerI

BioMérieux SAI

Product LaunchesII

Strategic Corporate DevelopmentsI

B. Market AnalyticsII

Table 72: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 73: French Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 74: French 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/ AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 75: French Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 76: French Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 77: French 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4b. GermanyII

A. Market AnalysisI

Market OverviewI

Few FactsI

Strategic Corporate DevelopmentsII

B. Market AnalyticsII

Table 78: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 79: German Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 80: German 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 81: German Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 82: German Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 83: German 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2000, 2005 & 2010 (includes corresponding Graph/Chart)II

4c. ItalyII

A. Market AnalysisI

Market OverviewI

Few FactsII

Table 84: HIV/ AIDS Prevalence and Mortality Rates by Age Group in Italy: End of 2003II

Strategic DevelopmentsI

B. Market AnalyticsII

Table 85: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 86: Italian Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 87: Italian 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

Table 88: Italian Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 89: Italian Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 90: Italian 10-Year Perspective for HIV/AIDS esting by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4d. The United KingdomII

A. Market AnalysisI

Market OverviewI

Trends in HIV and AIDS StatisticsII

At Risk Groups - A ReviewII

Table 91: HIV and AIDS Cases in the UK: Breakdown by Age Group and Gender: Till March 2006 (includes corresponding Graph/Chart)I

Table 92: AIDS Statistics for the UK by Exposure Category: Till June 2007 (includes corresponding Graph/Chart)II

B. Market AnalyticsII

Table 93: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 94: UK Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 95: UK 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit ales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 96: UK Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 97: UK Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/ AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 98: UK 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4e. SpainII

A. Market AnalysisI

Market OverviewI

B. Market AnalyticsII

Table 99: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 100: Spanish Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 101: Spanish 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 102: Spanish Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 103: Spanish Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 104: Spanish 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

4f. Rest of EuropeII

A. Market AnalysisI

Market OverviewI

AIDS ReviewI

AustriaI

RussiaII

Provision of Antiretroviral TreatmentI

UkraineI

Other European CountriesII

Key PlayersI

Innogenetics NV (Belgium)I

Roche Diagnostics (Switzerland)II

Strategic DevelopmentsII

B. Market AnalyticsII

Table 105: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 106: Rest of Europe Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 107: Rest of Europe 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 108: Rest of Europe Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 109: Rest of Europe Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 110: Rest of Europe 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

5. Asia PacificII

A. Market AnalysisI

Market OverviewI

The Next Epicenter for the AIDS EpidemicI

China and India: The Worst AffectedI

Review of Select Asian CountriesI

AustraliaII

Table 111: Number of HIV and AIDs Cases in Australia: Mid1990s to 2006 (includes corresponding Graph/Chart)II

Table 112: Number of AIDs Cases & Deaths in Australia by Age Group and Gender: End-2006 (includes corresponding Graph/Chart)I

Strategic DevelopmentI

ChinaI

AIDs/HIV- A ReviewII

Historical NoteI

Efforts to Combat HIV/ AIDsII

Strategic Corporate DevelopmentsII

India- Rapid Increase in HIVII

Table 113: HIV/AIDS Cases in India (2007): Percentage Breakup by Age GroupI

Table 114: Number of Live Persons Infection with HIV in Thailand: 2005-End (includes corresponding Graph/Chart)I

Product LaunchesI

Strategic DevelopmentII

SingaporeI

Strategic DevelopmentII

ThailandI

HIV Cases on DeclineII

Table 115: Number of Live Persons Infection with HIV in Thailand: 2005-End (includes corresponding Graph/Chart)I

Product LaunchesII

Strategic DevelopmentsI

PhilippinesI

2004: Hedley Receives Approval for INSTI(R) HIV-1/HIV-2 Antibody TestsI

KoreaI

2004: Roche to Supply COBAS AmpliScreen HIV-1 to Korean RedCrossI

VietnamII

Product Launches/ApprovalII

B. Market AnalyticsII

Table 116: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 117: Asia-Pacific Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 118: Asia Pacific 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 119: Asia Pacific Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 120: Asia-Pacific Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 121: Asia Pacific 10-Year Perspective for HIV/ AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

6. Latin AmericaII

A. Market AnalysisI

Market OverviewI

Epidemics of HIV in Latin AmericaII

Table 122: People Living with HIV Infection in Latin America by Country:2005 (includes corresponding Graph/Chart)II

Trends and Transmission ModesII

Table 123: HIV/AIDS Prevalence in Latin America: 2002-2004 (in Millions)II

Table 124: HIV/ AIDS Prevalence and Mortality Rates by Region till End of 2003I

Trends in Antiretroviral TreatmentII

Product Launches/ApprovalsI

Strategic Corporate DevelopmentsII

B. Market AnalyticsII

Table 125: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 126: Latin America Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 127: Latin America 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 128: Latin America Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/ AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 129: Latin America Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 130: Latin America 10-Year Perspective for HIV/ AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

7. Rest of WorldII

A. Market AnalysisI

Market OverviewI

AfricaI

Facing the Brunt of the DiseaseI

Mortality Rates on RiseII

Table 131: HIV/AIDS Cases in Africa as of End 2005: Breakdown By Top 20 CountriesII

Table 132: Adults & Children Deaths Due to AIDS in Africa (2005): Breakdown by Top 10 Countries (includes corresponding Graph/Chart)I

Table 133: Top 20 Countries in Sub-Saharan Africa by HIV/AIDS Prevalence Rate (2005) (includes corresponding Graph/Chart)I

Tanzania to Implement Second Phase of National Program for HIV/AIDS

TestingII

Uganda - A ReviewI

Product Launches/ApprovalsII

Strategic DevelopmentsII

Caribbean NationsII

Table 134: HIV/AIDS Prevalence & Mortality Rates in Caribbean Nations Till End of 2005I

Strategic DevelopmentsI

Iran II

Table 135: HIV infection in Iran: % Breakdown by Exposure Category (includes corresponding Graph/Chart)I

Saudi Arabia: Pre-marriage HIV Test to Become MandatoryI

B. Market AnalyticsII

Table 136: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in ‘000 Units for Years 2000 through 2010 (includes corresponding Graph/Chart)II

Table 137: Rest of World Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets Independently Analyzed with Annual Sales Figures in 000’ Units for Years 2011 through 2015 (includes corresponding Graph/Chart)I

Table 138: Rest of World 10-Year Perspective for HIV/AIDS Testing by Product Segment - Percentage Breakdown of Unit Sales for HIV/AIDS Screening Tests and HIV/AIDS Confirmatory Tests Markets for 2003, 2008 & 2012II

Table 139: Rest of World Recent Past, Current & Future Analysis for HIV/AIDS Testing by Product Segment - HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2000 through 2010 (includes corresponding Graph/Chart)I

Table 140: Rest of World Long-term Projections for HIV/AIDS Testing by Product Segment -HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, and HIV/AIDS Monitoring Tests Markets Independently Analyzed with Annual Sales Figures in US$ Millions for Years 2011 through 2015 (includes corresponding Graph/Chart)II

Table 141: Rest of World 10-Year Perspective for HIV/ AIDS Testing by Product Segment - Percentage Breakdown of Dollar Sales for HIV/AIDS Screening Tests, HIV/AIDS Confirmatory Tests, HIV/AIDS Monitoring Tests Markets for 2003, 2008 & 2012 (includes corresponding Graph/Chart)II

IV. COMPETITIVE LANDSCAPE

Total Companies Profiled: 62 (including Divisions/Subsidiaries - 69)

Region/Country Players

The United States

Canada

Europe

France

Germany

Italy

Rest of Europe

Asia-Pacific (Excluding Japan)

Middle East

Africa

Abstract

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.